Understanding COVID-19 Monoclonal Antibodies – A Webinar for Primary Care Providers

Fri, Feb 26th 2021 at 1:00 PM EST · By Healthcare Ready
Date & Time
Fri, Feb 26th 2021 at 1:00 PM EST
Fri, Feb 26th 2021 at 2:00 PM EST
Event Details

*Please register by selecting a ticket amount in the column to your right. You will receive an email confirmation with webinar information. Please remember to save the event to your calendar. *


Monoclonal antibody (mAbs) treatments represent an important tool in the fight against the COVID-19 pandemic. Made available through Emergency Use Authorization (EUA) by the FDA, mAb therapeutics can be life-saving for COVID-19 patients who are at high-risk of experiencing severe symptoms or hospitalization.

As the pandemic continues to strain the healthcare system and impact the health and wellness of communities across the country, using mAbs as an early treatment for COVID-19 patients can play a critical role in preventing hospitalization for vulnerable populations.

Healthcare Ready is hosting a webinar series on the use of mAbs for COVID-19 patients, specifically for primary care providers. 

Webinars will cover topics that include: patient eligibility, how mAbs are administered, the role of the government in allocation, and create a forum where healthcare providers who have direct experience administering mAbs can share their perspective and experience. 


1. Introduction to COVID-19 monoclonal antibodies (mAbs)

     a. Care pathways 

     b. Role and value of mAbs

     c. Patient eligibility 

2. Movement of mAbs

     a. Supply chain overview

     b. Direct ordering for facilities 

     c. Locator tools 

3. Provider Perspectives

     a. Saint Peters Health System (Albany, NY)

     b. Northwell Health (NYC)

4. Q&A

Session Objectives

  • Provide a forum for primary care providers to learn and ask questions about monoclonal antibodies (mAbs);
  • Gain insights and best practices from providers with experience administering mAbs and increasing infusion capabilities; and
  • Provide resources and tools for providers to identify how to access mAb therapeutics for the treatment of COVID-19 patients.


Dr. Melissa Fiorini; Director, mAbs Infusion Clinic for COVID-19, Saint Peter's Health Partners

Melissa Fiorini, M.D., FACP is a critical care and emergency medicine physician at St. Peter’s Health Partners (SPHP). She currently serves as the director of the healthcare system’s monoclonal antibody infusion clinic for COVID-19. Dr. Fiorini has been a member of SPHP since 2012, practicing in all areas of acute care medicine from the ICU and emergency room to urgent care. Initially focusing on sepsis, she now works to secure safe protocols for her patients and co-workers as part of the COVID-19 response. As director of the monoclonal antibody infusion clinic for COVID-19, the first clinic of its kind in the region, Dr Fiorini has overseen the treatment of 600 patients in the few months since its inception.

Dr. Mark Jarrett; Senior Vice President and Chief Quality Officer, Northwell Health

As Chief Quality Officer for Northwell Health, Mark P. Jarrett, MD, MBA, is responsible for system-wide initiatives in quality and safety. Dr. Jarrett is also Northwell’s deputy chief medical officer and a professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He previously served as Chief Medical Officer and DIO at Staten Island University Hospital (SIUH). Prior to that appointment, Dr. Jarrett was director of Rheumatology at SIUH from 1982-1999. Dr. Jarrett has extensive research experience and has been published on the subject of the immune response in systemic lupus erythematosus, quality and cybersecurity in health care.

Dr. Tricia Coleman; Senior Director of Medical Affairs, Regeneron Pharmaceuticals

Tricia Coleman received her BS in biology from the University of Nebraska-Lincoln and PhD in biochemistry from the University of Southern Mississippi where she studied functional RNAs. Following a post-doctoral fellowship at the Nebraska Center for Virology, she joined the pharmaceutical industry where she has served in several capacities across medical affairs organizations over a 15-year career. She is currently a Sr. Director of Medial Affairs at Regeneron Pharmaceuticals working with the casirivimab and imdevimab program.

Audience: This event is intended for primary care providers, including providers and operational staff at community health centers (CHCs) and federally-qualified heath centers (FQHCs.)

  *This event will be recorded and made publicly available following the event*

+ Show All Tier Details
Clear Cart